Anzeige
Mehr »
Login
Donnerstag, 07.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
357 Leser
Artikel bewerten:
(2)

IranWire Publishes Special Report on 'Blinding as a Weapon of Suppression' in Iran

Collaborative news site documented more than 50 serious eye injuries sustained by protestors over the past five months; evidence points to thousands more

LONDON, March 14, 2023 (GLOBE NEWSWIRE) -- IranWire, a news website run by professional Iranian journalists in the diaspora and citizen journalists inside Iran, today released a special report detailing the use of blinding as a weapon of suppression by the Islamic Republic of Iran since mostly peaceful anti-government demonstrations began in September 2022.

The report, "Blinding as a Weapon of Suppression in Iran,"documents dozens of serious eye injuries sustained by protestors and bystanders. It also shares anecdotal evidence of there being thousands more victims who are reluctant or unable to access care because of the presence of security forces in hospitals and clinics across Iran. Though media outlets occasionally mention that protestors suffer eye injuries after being hit by metal pellets, rubber bullets and tear gas, the widespread and systematic use of blinding as a weapon of suppression has until now been largely undocumented.

In addition to detailing the specific cases of more than 20 survivors, IranWire's report dives into the medical, physical and psychological consequences of blinding. The authors, Aida Ghajar, Katherine Hignett and Omid Shams, reviewed medical records and consulted with medical and legal experts to draw conclusions in the report.

"The Islamic Republic's systematic use of blinding as a weapon of suppression is a perfect example of a minimally reported story just now being brought to light because of the bravery of citizen journalists and our courageous reporters in the diaspora," said Maziar Bahari, IranWire's founder and executive director. "Our colleague Aida Ghajar, who lives in France, has dedicated her time to finding dozens of people across Iran who have been blinded by the regime. IranWire exists to hold leaders accountable for their actions. We hope "Blinding as a Weapon of Suppression in Iran" raises awareness of the dangers protesters and bystanders face in Iran. The international community must act quickly and force the government of Iran to stop these heinous acts against innocent people."

IranWire, which publishes in five languages, has trained more than 5,000 citizen journalists in Iran since its founding by Bahari in 2013.

The protests were sparked by the death of 22-year-old Iranian woman Mahsa Amini, who was arrested in Tehran for what authorities deemed as improperly wearing her hijab. She died Sept. 16 while in police custody. Protests began in Tehran shortly after her death and quickly spread to other parts of the country. Ghajar was the journalist who first reported Amini's hospitalization in September 2022.

Severe eye injuries have been reported by protestors in many Iranian cities, including Tehran, Alborz, Isfahan, West Azerbaijan and Kurdistan provinces, pointing to an organized effort to suppress protests by maiming participants. The cases in the IranWire report represent victims mostly under the age of 40, including a 5-year-old who was shot 20 times with metal pellets and permanently lost vision in her left eye.

"Blinding as a Weapon of Suppression in Iran" also includes a review by Iranian-American ophthalmologists of the injuries and prognoses for survivors, through analysis of medical records from 12 people who sustained injuries.

"The fact that eye patches have become a symbol of pride among demonstrators in Iran shows a clear link between the demonstrations and blinding as a weapon to suppress these protests," Hignett said in the report. "This report is an attempt to document a small portion of these injuries."

About IranWire
IranWire, founded in 2013 by Maziar Bahari and owned by Off-Centre Productions, a UK-based company, is a collaborative news website run by professional Iranian journalists in the diaspora and citizen journalists inside Iran. IranWire empowers reporters and activists by creating a safe space in which they can share and discuss local and national affairs, in an environment free of censorship or coercion. We share our analysis with audiences around the world, publishing in several languages including Persian, English, Arabic, Kurdish, Azerbaijani, and Spanish. To learn more, visit www.iranwire.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/eeb52a23-dcad-4801-adcc-7b12ffb3b1d4


© 2023 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.